All News

Convention1.jpg

Preview of EULAR 2019 Abstracts

d Jack Cush, MD

EULAR 2019 begins today in Madrid and features over 2000 presentations.  After an initial review of titles and abstracts, I’ve compiled a hit list of presentations of interest to me and hopefully other practicing rheumatologists.  

Read Article
MAS.jpg

Management of Hemophagocytic Lymphohistiocytosis (HLH) in Adults

d Jack Cush, MD

Hemophagocytic lymphohistiocytosis (HLH) is a severe hyperinflammatory syndrome induced by activated macrophages and cytotoxic T cells.  HLH manifests recurrent fever, cytopenia, liver dysfunction, and a sepsis-like syndrome that may complicated by multiple organ failure.

Read Article
gout.MTP1_.jpg

Updated 2018 EULAR Recommendations for the Diagnosis of Gout

d Jack Cush, MD

The first EULAR recommendations for the diagnosis of gout were published in 2006. A task force was formed and following a systematic review, they voted unanimously for changes in all items of the 2006 recommendations.

Read Article
Filippou shows us US vs synovial exam of crystal: US more sensitive but less specific than synovial aspirate. Beware the double contour sign in CPPD mimicking gout but calcification moves discordant with the bone. #eular2019 @RheumNow https://t.co/W8pftdfa0I
Alberta Hoi tuna0sashimi ( View Tweet)
OA is multifactorial. So why do we expect a silver bullet therapeutic solution? Rik Lories on manipulating signaling pathways for treating OA #EULAR2019 SP0013 @RheumNow https://t.co/0g2ZLT4XfN
David Liew drdavidliew ( View Tweet)
@benjaminsutu @dr_rachelblack @tuna0sashimi @RheumNow You want puns? We got puns https://t.co/MxGSOE9BI7
David Liew drdavidliew ( View Tweet)
Do NSAIDs work in Axial Spondyloarthritis? YES! The all work but none is better or safer than the others #EULAR 2019 abstr SP0003 https://t.co/z2Dp8Cf2PV
Dr. John Cush RheumNow ( View Tweet)
CPPD together with syphilis and TB as the great mimicker in rheumatology #eular2019 @RheumNow

Alberta Hoi tuna0sashimi ( View Tweet)

The very first WIN and HOT session is about to begin. Join us as we explore ‘New Avenues of OA & Osteoporosis Management’ in Hall 6 at 14.15.(CEST). See it on the move on @YouTubeTV #EULARLIVE: https://t.co/LojAOi4cAZ https://t.co/eoggidKWZ9

Links:

EULAR | The European League Against Rheumatism eular_org ( View Tweet)
Acetaminophen had more diarrhea and transaminitis than placebo in RCTS. In nonrandomized studies there were 1.4 times more UGI bleeds but likely channeling bias. Ok for CV events in RCTs; mixed results in uncontrolled studies for CV and renal. @RheumNow #EULAR2019 0P0019-HPR https://t.co/Y8f87jnxbR
Janet Pope Janetbirdope ( View Tweet)
Good news for scleroderma lung disease. Abstract OP0017 shows less decline in SSc ILD with nintedanib v placebo. Half on MMF in both groups. Less decline if on MMF but still 40% reduction in active v placebo in both subsets and combination seemed safe. @RheumNow #EULAR2019 https://t.co/1CJ4sggZsj
Janet Pope Janetbirdope ( View Tweet)
Go Ai Li! Winner of clinical science abstract awards @Monash_FMNHS @RheumNow #eular2019 https://t.co/7cLYREEAlY
Alberta Hoi tuna0sashimi ( View Tweet)
Looking forward to joining Jack and the rest of the team in reporting for @RheumNow from #EULAR2019 in sunny Madrid this week! https://t.co/WLhaq2KtsR https://t.co/BJGxfDKfcA

Links:

David Liew drdavidliew ( View Tweet)
Plenary session of JIA post TNFI failure OP0016 from 2 UK registries by Kearsley-Fleet shows no difference in 151 kids who go to 2nd TNFi vs switch to different biologic for response and retention. Either is ok. @RheumNow #EULAR2019

Janet Pope Janetbirdope ( View Tweet)

UK study shows SLE admissions increased from 8.97 to 9.04 per 100,000 ( p < 0.001) between 1998 & 2015. By comparison, RA admissions rose from 71.0 to 171.6 per 100,000 ( p < 0.001). YET total bed days for SLE & RA fell by 60% and 90%, respectively https://t.co/5IeZh8o8M5

Links:

Dr. John Cush RheumNow ( View Tweet)

EULAR is a truly pan-European organisation fostering a multitude of activities in areas of research, patient care, and education. Learn more at #EULAR2019! #rheumatology #rheumarthritis #lupus https://t.co/sGSuKnXpNg
EULAR | The European League Against Rheumatism eular_org ( View Tweet)
NHANES study shows Psoriatic arthritis found that #PsA patients report more hearing difficulties (OR 1.50, p 0.043), visit mental health provider (OR 1.62, p = 0.084), 1.62 more days of poor mental health (p = 0.033), and depression (OR 2.01, p = 0.015) https://t.co/xdh4MfWxbA

Links:

Dr. John Cush RheumNow ( View Tweet)

https://t.co/V10S4oVFsv would love to feature your tweets in our coverage of #EULAR2019 from Madrid. Be sure to include these 3 in your tweet- @RheumNow #EULAR2019 & the abstract # https://t.co/WqqX4w4dmd

Links:

Dr. John Cush RheumNow ( View Tweet)
GSK announced that the FDA has approved the IL-5 inhibitor Nucala (mepolizumab), as an autoinjector and a pre-filled safety syringe, (for use in severe eosinophilic asthma & disease eosinophilic granulomatosis with polyangiitis (EGPA) https://t.co/XXGJxLDta7

Links:

Dr. John Cush RheumNow ( View Tweet)

Hear nine experts talk about biosimilars in “Therapeutic Update: Biosimilars in Rheumatology”, a video series brought to viewers by Sandoz. Now available on RheumNow. https://t.co/1vmnEJqOSi #sponsored #biosimilars

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×